Administration and patient-incurred costs associated with opioid agonist treatment in Norway.
Mikkel Hasse PedersenAnne DanøCarl GibbonsRasmus JensenPublished in: Current medical research and opinion (2022)
The analysis showed that the monthly formulation of SC-BPN was the cost-minimising alternative, followed by the weekly formulation, when considering all cost components.